Is schizophrenia a lifetime disorder of brain plasticity, growth and aging?
- PMID: 9061808
- DOI: 10.1016/S0920-9964(96)00079-5
Is schizophrenia a lifetime disorder of brain plasticity, growth and aging?
Abstract
Chronic schizophrenia is characterized by change in the normal brain cortical structure, asymmetric reduction, and ventricular enlargement. The debate continues as to whether these anomalies occur early in development or represent an active progressive process continuing after the onset of psychosis. The case is made in the present manuscript for a continuing aberrant lifetime brain process. It is proposed that the underlying basis for the neuropathology of schizophrenia resides in the periodic activation of a defective gene or genes that determine the rate of cerebral growth. This process causes subtle cortical maldevelopment prenatally and through early childhood, is activated again during adolescent pruning of neurons, and again during the gradual aging process in the brain throughout adulthood. The case for a progressive active brain process in schizophrenia is thus presented.
Similar articles
-
Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.Arch Gen Psychiatry. 2003 Jun;60(6):585-94. doi: 10.1001/archpsyc.60.6.585. Arch Gen Psychiatry. 2003. PMID: 12796222
-
Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses.Arch Gen Psychiatry. 2004 Jan;61(1):17-22. doi: 10.1001/archpsyc.61.1.17. Arch Gen Psychiatry. 2004. PMID: 14706940
-
Use of antipsychotic medication in the elderly.Annu Rev Gerontol Geriatr. 1984;4:175-220. Annu Rev Gerontol Geriatr. 1984. PMID: 6152711 Review. No abstract available.
-
Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection.CNS Spectr. 2006 Apr;11(4):suppl 1-13; quiz suppl 14-5. CNS Spectr. 2006. PMID: 16641837
-
Developmental trajectory and disease progression in schizophrenia: the conundrum, and insights from a 12-year prospective study in the Monaghan 101.Schizophr Res. 1997 Feb 7;23(2):107-18. doi: 10.1016/S0920-9964(96)00111-9. Schizophr Res. 1997. PMID: 9061807 Review.
Cited by
-
Effect fingerprints of antipsychotic drugs on neural networks in vitro.J Neural Transm (Vienna). 2019 Oct;126(10):1363-1371. doi: 10.1007/s00702-019-02050-8. Epub 2019 Jul 18. J Neural Transm (Vienna). 2019. PMID: 31321550
-
Diffusion tensor imaging of anterior commissural fibers in patients with schizophrenia.Schizophr Res. 2011 Aug;130(1-3):78-85. doi: 10.1016/j.schres.2011.04.016. Epub 2011 May 10. Schizophr Res. 2011. PMID: 21561738 Free PMC article.
-
Grey matter and cognitive deficits in young relatives of schizophrenia patients.Neuroimage. 2011 Jan;54 Suppl 1(0 1):S287-92. doi: 10.1016/j.neuroimage.2010.03.069. Epub 2010 Mar 31. Neuroimage. 2011. PMID: 20362681 Free PMC article.
-
Cortical Volume Differences in Subjects at Risk for Psychosis Are Driven by Surface Area.Schizophr Bull. 2020 Dec 1;46(6):1511-1519. doi: 10.1093/schbul/sbaa066. Schizophr Bull. 2020. PMID: 32463880 Free PMC article.
-
Animal models of schizophrenia: a critical review.J Psychiatry Neurosci. 2001 Nov;26(5):395-410. J Psychiatry Neurosci. 2001. PMID: 11762207 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical